{
    "2021-01-28": [
        [
            {
                "time": "2021-03-01",
                "original_text": "Honeywell’s Global Supply Chain Chief on how the company administered 16K vaccinations in one weekend",
                "features": {
                    "keywords": [
                        "Honeywell",
                        "vaccinations",
                        "supply chain"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "logistics"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "FOCUS-Racing the virus: Why tweaking vaccines to fight variants won't be simple",
                "features": {
                    "keywords": [
                        "virus",
                        "variants",
                        "vaccines"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "This Company May Be the Next to Cross the Coronavirus Vaccine Finish Line",
                "features": {
                    "keywords": [
                        "Company",
                        "Coronavirus",
                        "Vaccine"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "If You're Retired, Consider Buying These 2 Stocks",
                "features": {
                    "keywords": [
                        "Retired",
                        "Buying",
                        "Stocks"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "5 Big Pharma/Biotech Stocks Set to Trump Q4 Earnings Estimates",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Biotech",
                        "Earnings"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "German Authorities Won’t Recommend AstraZeneca Vaccine for People Over 65",
                "features": {
                    "keywords": [
                        "German",
                        "Authorities",
                        "AstraZeneca",
                        "Vaccine"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "Moderna and Pfizer Vaccines Still Look Safe, CDC Says",
                "features": {
                    "keywords": [
                        "Moderna",
                        "Pfizer",
                        "Vaccines",
                        "CDC"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "3 Great Stocks for Low-Risk Investors",
                "features": {
                    "keywords": [
                        "Great",
                        "Stocks",
                        "Low-Risk",
                        "Investors"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "FOCUS-Racing the virus: Why tweaking the vaccines won't be simple",
                "features": {
                    "keywords": [
                        "virus",
                        "tweaking",
                        "vaccines"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}